Il'yasova, Dora <br/><br/>
Urinary F2-isoprostanes are not associated with increased risk of type 2 diabetes.  [electronic resource] 

 -  Obesity research  Sep 2005 
 - 1638-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1071-7323 
<br/><br/><label>Standard No.: </label>10.1038/oby.2005.201  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Case-Control Studies<br/>Diabetes Mellitus, Type 2--etiology<br/>F2-Isoprostanes--urine<br/>Female<br/>Humans<br/>Lipid Peroxidation--physiology<br/>Male<br/>Middle Aged<br/>Oxidative Stress--physiology<br/>Pilot Projects<br/>Regression Analysis<br/>Risk Factors<br/>Statistics, Nonparametric